Joint Effect of Hypertension and Elevated Serum Phosphorus on the Risk of Mortality in National Health and Nutrition Examination Survey-III

Article English OPEN
Vart, Priya ; Nigatu, Yeshambel T. ; Jaglan, Ajay ; van Zon, Sander K. R. ; Shafique, Kashif (2015)
  • Publisher: Wiley
  • Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (issn: 2047-9980, vol: 4)
  • Related identifiers: doi: 10.1161/jaha.114.001706, pmc: PMC4599407
  • Subject: interaction | mortality | Original Research | serum phosphorus | hypertension | RERI

Background Elevated serum phosphorus might aggravate the effect of hypertension on mortality. The objective of this study was to examine the joint effect of hypertension and serum phosphorus on the risk of mortality.\ud \ud Methods and Results A large prospective (n=15 833), population‐based cohort of participants from the National Health and Nutritional Examination Survey III was examined to test potential synergism between hypertension, elevated serum phosphorus, and the risk of mortality. Interaction on additive scale and multiplicative scale was estimated. After a median follow‐up of 14.3 years, 1691 cases of cardiovascular mortality and 3875 cases of all‐cause mortality were identified. Interaction was observed between hypertension and elevated serum phosphorus on the additive scale for cardiovascular mortality (relative excess risk due to interaction, 0.99, 95% CI: 0.06; 1.92, adjusted for age, gender, race, and estimated glomerular filtration rate). No statistically significant interaction was found between hypertension and serum phosphorus for all‐cause mortality on the additive scale. No significant interaction was detected on the multiplicative scale. In sensitivity analysis, excluding participants who died in first 2 years and adjustment for additional confounders resulted in essentially similar findings.\ud \ud Conclusions The joint effect of hypertension and elevated serum phosphorus was larger than the sum of the independent effects on cardiovascular mortality but not on all‐cause mortality. Future studies should investigate whether controlling elevated serum phosphorus in hypertensive individuals helps in prevention of extra risk of cardiovascular mortality.
  • References (28)
    28 references, page 1 of 3

    1. Lawes CM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2003;371:1513-1518.

    2. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S; American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Hypertension. 2007;50: e28-e55.

    3. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, Wiebe N, Muntner P. Relation between alkaline phosphatase, serum phosphate, and allcause or cardiovascular mortality. Circulation. 2009;120:1784-1792.

    4. Dhingra R, Sullivan LM, Fox CS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167:879-885.

    5. Lederer E. Regulation of serum phosphate. J Physiol. 2014;592:3985-3995.

    6. Ketteler M, Wolf M, Hahn K, Ritz E. Phosphate: a novel cardiovascular risk factor. Eur Heart J. 2013;34:1099-1101.

    7. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20:381-387.

    8. Frohlich ED. Risk mechanisms in hypertensive heart disease. Hypertension. 1999;34:782-789.

    9. Beevers GL. The pathophysiology of hypertension. BMJ. 2001;322:912-916.

    10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.

  • Metrics
    No metrics available
Share - Bookmark